Criteria used when initiating antifungal therapy against Candida spp. in the intensive care unit
- 13 June 2000
- journal article
- review article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 15 (2), 83-90
- https://doi.org/10.1016/s0924-8579(00)00147-3
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- The Epidemiology of Hematogenous Candidiasis Caused by Different Candida SpeciesClinical Infectious Diseases, 1997
- NOSOCOMIAL CANDIDA: Epidemiology, Transmission, and PreventionInfectious Disease Clinics of North America, 1997
- Nosocomial Bacteremia in Critically Ill Patients: A Multicenter Study Evaluating Epidemiology and PrognosisClinical Infectious Diseases, 1997
- Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapyIntensive Care Medicine, 1997
- Candidemia in intensive care unit patients: Risk factors for mortalityInfection, 1997
- Problems and Controversies in the Management of Hematogenous CandidiasisClinical Infectious Diseases, 1996
- Nosocomial Candidemia: Risk Factors and Attributable MortalityClinical Infectious Diseases, 1995
- Candida Colonization and Subsequent Infections in Critically III Surgical PatientsAnnals of Surgery, 1994
- Candidemia in a Tertiary Care Hospital: Epidemiology, Risk Factors, and Predictors of MortalityClinical Infectious Diseases, 1992
- Hospital-acquired candidemia. The attributable mortality and excess length of stayArchives of Internal Medicine, 1988